Global Companion Cancer Diagnostics Market Growth (Status and Outlook) 2020-2025
Apr, 2020
|
Report ID: 123847
|
116
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Companion Cancer Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Companion Cancer Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Companion Cancer Diagnostics market by type, application, key companies and key regions.
This study considers the Companion Cancer Diagnostics value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Gastric Cancer
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
CROs
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche
Agilent Technologies
Abbott Laboratories
Almac Group
QIAGEN
Myriad Genetics
Danaher Corporation
bioM_rieuxSA
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Companion Cancer Diagnostics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Companion Cancer Diagnostics market by identifying its various subsegments.
Focuses on the key global Companion Cancer Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Companion Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Companion Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares and growth opportunities of Companion Cancer Diagnostics market by type, application, key companies and key regions.
This study considers the Companion Cancer Diagnostics value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Gastric Cancer
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
CROs
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche
Agilent Technologies
Abbott Laboratories
Almac Group
QIAGEN
Myriad Genetics
Danaher Corporation
bioM_rieuxSA
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Companion Cancer Diagnostics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Companion Cancer Diagnostics market by identifying its various subsegments.
Focuses on the key global Companion Cancer Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Companion Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Companion Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Companion Cancer Diagnostics Market Size 2015-2025
2.1.2 Companion Cancer Diagnostics Market Size CAGR by Region
2.2 Companion Cancer Diagnostics Segment by Type
2.2.1 Breast Cancer
2.2.2 Breast Cancer
2.2.3 Colorectal Cancer
2.2.4 Melanoma
2.2.5 Gastric Cancer
2.3 Companion Cancer Diagnostics Market Size by Type
2.3.1 Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
2.3.2 Global Companion Cancer Diagnostics Market Size Growth Rate by Type (2015-2020)
2.4 Companion Cancer Diagnostics Segment by Application
2.4.1 Pharmaceutical & Biopharmaceutical Companies
2.4.2 Reference Laboratories
2.4.3 CROs
2.4.4 Others
2.5 Companion Cancer Diagnostics Market Size by Application
2.5.1 Global Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
2.5.2 Global Companion Cancer Diagnostics Market Size Growth Rate by Application (2015-2020)
3 Global Companion Cancer Diagnostics by Players
3.1 Global Companion Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Companion Cancer Diagnostics Market Size by Players (2018-2020)
3.1.2 Global Companion Cancer Diagnostics Market Size Market Share by Players (2018-2020)
3.2 Global Companion Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Companion Cancer Diagnostics by Regions
4.1 Companion Cancer Diagnostics Market Size by Regions
4.2 Americas Companion Cancer Diagnostics Market Size Growth
4.3 APAC Companion Cancer Diagnostics Market Size Growth
4.4 Europe Companion Cancer Diagnostics Market Size Growth
4.5 Middle East & Africa Companion Cancer Diagnostics Market Size Growth
5 Americas
5.1 Americas Companion Cancer Diagnostics Market Size by Countries
5.2 Americas Companion Cancer Diagnostics Market Size by Type
5.3 Americas Companion Cancer Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Companion Cancer Diagnostics Market Size by Regions
6.2 APAC Companion Cancer Diagnostics Market Size by Type
6.3 APAC Companion Cancer Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Companion Cancer Diagnostics by Countries
7.2 Europe Companion Cancer Diagnostics Market Size by Type
7.3 Europe Companion Cancer Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Companion Cancer Diagnostics by Countries
8.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Type
8.3 Middle East & Africa Companion Cancer Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Companion Cancer Diagnostics Market Forecast
10.1 Global Companion Cancer Diagnostics Market Size Forecast (2021-2025)
10.2 Global Companion Cancer Diagnostics Forecast by Regions
10.2.1 Global Companion Cancer Diagnostics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Companion Cancer Diagnostics Forecast by Type
10.8 Global Companion Cancer Diagnostics Forecast by Application
11 Key Players Analysis
11.1 F. Hoffmann-La Roche
11.1.1 Company Details
11.1.2 Companion Cancer Diagnostics Product Offered
11.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 F. Hoffmann-La Roche News
11.2 Agilent Technologies
11.2.1 Company Details
11.2.2 Companion Cancer Diagnostics Product Offered
11.2.3 Agilent Technologies Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Agilent Technologies News
11.3 Abbott Laboratories
11.3.1 Company Details
11.3.2 Companion Cancer Diagnostics Product Offered
11.3.3 Abbott Laboratories Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Abbott Laboratories News
11.4 Almac Group
11.4.1 Company Details
11.4.2 Companion Cancer Diagnostics Product Offered
11.4.3 Almac Group Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Almac Group News
11.5 QIAGEN
11.5.1 Company Details
11.5.2 Companion Cancer Diagnostics Product Offered
11.5.3 QIAGEN Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 QIAGEN News
11.6 Myriad Genetics
11.6.1 Company Details
11.6.2 Companion Cancer Diagnostics Product Offered
11.6.3 Myriad Genetics Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Myriad Genetics News
11.7 Danaher Corporation
11.7.1 Company Details
11.7.2 Companion Cancer Diagnostics Product Offered
11.7.3 Danaher Corporation Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Danaher Corporation News
11.8 bioM_rieuxSA
11.8.1 Company Details
11.8.2 Companion Cancer Diagnostics Product Offered
11.8.3 bioM_rieuxSA Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 bioM_rieuxSA News
12 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Companion Cancer Diagnostics Market Size 2015-2025
2.1.2 Companion Cancer Diagnostics Market Size CAGR by Region
2.2 Companion Cancer Diagnostics Segment by Type
2.2.1 Breast Cancer
2.2.2 Breast Cancer
2.2.3 Colorectal Cancer
2.2.4 Melanoma
2.2.5 Gastric Cancer
2.3 Companion Cancer Diagnostics Market Size by Type
2.3.1 Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
2.3.2 Global Companion Cancer Diagnostics Market Size Growth Rate by Type (2015-2020)
2.4 Companion Cancer Diagnostics Segment by Application
2.4.1 Pharmaceutical & Biopharmaceutical Companies
2.4.2 Reference Laboratories
2.4.3 CROs
2.4.4 Others
2.5 Companion Cancer Diagnostics Market Size by Application
2.5.1 Global Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
2.5.2 Global Companion Cancer Diagnostics Market Size Growth Rate by Application (2015-2020)
3 Global Companion Cancer Diagnostics by Players
3.1 Global Companion Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Companion Cancer Diagnostics Market Size by Players (2018-2020)
3.1.2 Global Companion Cancer Diagnostics Market Size Market Share by Players (2018-2020)
3.2 Global Companion Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Companion Cancer Diagnostics by Regions
4.1 Companion Cancer Diagnostics Market Size by Regions
4.2 Americas Companion Cancer Diagnostics Market Size Growth
4.3 APAC Companion Cancer Diagnostics Market Size Growth
4.4 Europe Companion Cancer Diagnostics Market Size Growth
4.5 Middle East & Africa Companion Cancer Diagnostics Market Size Growth
5 Americas
5.1 Americas Companion Cancer Diagnostics Market Size by Countries
5.2 Americas Companion Cancer Diagnostics Market Size by Type
5.3 Americas Companion Cancer Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Companion Cancer Diagnostics Market Size by Regions
6.2 APAC Companion Cancer Diagnostics Market Size by Type
6.3 APAC Companion Cancer Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Companion Cancer Diagnostics by Countries
7.2 Europe Companion Cancer Diagnostics Market Size by Type
7.3 Europe Companion Cancer Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Companion Cancer Diagnostics by Countries
8.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Type
8.3 Middle East & Africa Companion Cancer Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Companion Cancer Diagnostics Market Forecast
10.1 Global Companion Cancer Diagnostics Market Size Forecast (2021-2025)
10.2 Global Companion Cancer Diagnostics Forecast by Regions
10.2.1 Global Companion Cancer Diagnostics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Companion Cancer Diagnostics Forecast by Type
10.8 Global Companion Cancer Diagnostics Forecast by Application
11 Key Players Analysis
11.1 F. Hoffmann-La Roche
11.1.1 Company Details
11.1.2 Companion Cancer Diagnostics Product Offered
11.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 F. Hoffmann-La Roche News
11.2 Agilent Technologies
11.2.1 Company Details
11.2.2 Companion Cancer Diagnostics Product Offered
11.2.3 Agilent Technologies Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Agilent Technologies News
11.3 Abbott Laboratories
11.3.1 Company Details
11.3.2 Companion Cancer Diagnostics Product Offered
11.3.3 Abbott Laboratories Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Abbott Laboratories News
11.4 Almac Group
11.4.1 Company Details
11.4.2 Companion Cancer Diagnostics Product Offered
11.4.3 Almac Group Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Almac Group News
11.5 QIAGEN
11.5.1 Company Details
11.5.2 Companion Cancer Diagnostics Product Offered
11.5.3 QIAGEN Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 QIAGEN News
11.6 Myriad Genetics
11.6.1 Company Details
11.6.2 Companion Cancer Diagnostics Product Offered
11.6.3 Myriad Genetics Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Myriad Genetics News
11.7 Danaher Corporation
11.7.1 Company Details
11.7.2 Companion Cancer Diagnostics Product Offered
11.7.3 Danaher Corporation Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Danaher Corporation News
11.8 bioM_rieuxSA
11.8.1 Company Details
11.8.2 Companion Cancer Diagnostics Product Offered
11.8.3 bioM_rieuxSA Companion Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 bioM_rieuxSA News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Companion Cancer Diagnostics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Breast Cancer
Table 5. Major Players of Lung Cancer
Table 6. Major Players of Colorectal Cancer
Table 7. Major Players of Melanoma
Table 8. Major Players of Gastric Cancer
Table 9. Companion Cancer Diagnostics Market Size by Type (2014-2019) ($ Millions)
Table 10. Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 11. Global Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 13. Global Companion Cancer Diagnostics Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Companion Cancer Diagnostics Revenue Market Share by Players (2018-2020)
Table 15. Global Companion Cancer Diagnostics Key Players Head office and Products Offered
Table 16. Companion Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Cancer Diagnostics Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Companion Cancer Diagnostics Market Size Market Share by Regions 2015-2020
Table 21. Americas Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 23. Americas Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 25. Americas Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 27. APAC Companion Cancer Diagnostics Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Companion Cancer Diagnostics Market Size Market Share by Regions (2015-2020)
Table 29. APAC Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 31. APAC Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 33. Europe Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 35. Europe Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 37. Europe Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Companion Cancer Diagnostics
Table 46. Key Application and Potential Industries of Companion Cancer Diagnostics
Table 47. Key Challenges of Companion Cancer Diagnostics
Table 48. Key Trends of Companion Cancer Diagnostics
Table 49. Global Companion Cancer Diagnostics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Regions
Table 51. Global Companion Cancer Diagnostics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global Companion Cancer Diagnostics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Application (2021-2025)
Table 55. F. Hoffmann-La Roche Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 56. F. Hoffmann-La Roche Companion Cancer Diagnostics Product Offered
Table 57. F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Latest Developments
Table 60. Agilent Technologies Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 61. Agilent Technologies Companion Cancer Diagnostics Product Offered
Table 62. Agilent Technologies Main Business
Table 63. Agilent Technologies Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 64. Agilent Technologies Latest Developments
Table 65. Abbott Laboratories Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 66. Abbott Laboratories Companion Cancer Diagnostics Product Offered
Table 67. Abbott Laboratories Main Business
Table 68. Abbott Laboratories Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 69. Abbott Laboratories Latest Developments
Table 70. Almac Group Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 71. Almac Group Companion Cancer Diagnostics Product Offered
Table 72. Almac Group Main Business
Table 73. Almac Group Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 74. Almac Group Latest Developments
Table 75. QIAGEN Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 76. QIAGEN Companion Cancer Diagnostics Product Offered
Table 77. QIAGEN Main Business
Table 78. QIAGEN Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 79. QIAGEN Latest Developments
Table 80. Myriad Genetics Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 81. Myriad Genetics Companion Cancer Diagnostics Product Offered
Table 82. Myriad Genetics Main Business
Table 83. Myriad Genetics Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 84. Myriad Genetics Latest Developments
Table 85. Danaher Corporation Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 86. Danaher Corporation Companion Cancer Diagnostics Product Offered
Table 87. Danaher Corporation Main Business
Table 88. Danaher Corporation Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 89. Danaher Corporation Latest Developments
Table 90. bioM_rieuxSA Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 91. bioM_rieuxSA Companion Cancer Diagnostics Product Offered
Table 92. bioM_rieuxSA Main Business
Table 93. bioM_rieuxSA Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 94. bioM_rieuxSA Latest Developments
List of Figures
Figure 1. Companion Cancer Diagnostics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Companion Cancer Diagnostics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Figure 5. Global Breast Cancer Market Size Growth Rate
Figure 6. Global Lung Cancer Market Size Growth Rate
Figure 7. Global Colorectal Cancer Market Size Growth Rate
Figure 8. Global Melanoma Market Size Growth Rate
Figure 9. Global Gastric Cancer Market Size Growth Rate
Figure 10. Companion Cancer Diagnostics in Pharmaceutical & Biopharmaceutical Companies
Figure 11. Global Companion Cancer Diagnostics Market: Pharmaceutical & Biopharmaceutical Companies (2015-2020) ($ Millions)
Figure 12. Companion Cancer Diagnostics in Reference Laboratories
Figure 13. Global Companion Cancer Diagnostics Market: Reference Laboratories (2015-2020) ($ Millions)
Figure 14. Companion Cancer Diagnostics in CROs
Figure 15. Global Companion Cancer Diagnostics Market: CROs (2015-2020) ($ Millions)
Figure 16. Global CROs YoY Growth ($ Millions)
Figure 17. Companion Cancer Diagnostics in Others
Figure 18. Global Companion Cancer Diagnostics Market: Others (2015-2020) ($ Millions)
Figure 19. Global Others YoY Growth ($ Millions)
Figure 20. Global Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 21. Global Companion Cancer Diagnostics Market Size Market Share by Regions 2015-2020
Figure 22. Americas Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 23. APAC Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 24. Europe Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 26. Americas Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 27. Americas Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 28. Americas Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 29. United States Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Companion Cancer Diagnostics Market Size Market Share by Regions in 2019
Figure 33. APAC Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 34. APAC Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 35. China Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 42. Europe Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 43. Europe Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 44. Germany Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 53. Egypt Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Companion Cancer Diagnostics arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 60. APAC Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 61. Europe Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 63. United States Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 64. Canada Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 67. China Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 68. Japan Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 69. Korea Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 71. India Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 72. Australia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 73. Germany Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 74. France Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 75. UK Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 76. Italy Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 77. Russia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 78. Spain Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 81. Israel Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Companion Cancer Diagnostics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Breast Cancer
Table 5. Major Players of Lung Cancer
Table 6. Major Players of Colorectal Cancer
Table 7. Major Players of Melanoma
Table 8. Major Players of Gastric Cancer
Table 9. Companion Cancer Diagnostics Market Size by Type (2014-2019) ($ Millions)
Table 10. Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 11. Global Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 13. Global Companion Cancer Diagnostics Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Companion Cancer Diagnostics Revenue Market Share by Players (2018-2020)
Table 15. Global Companion Cancer Diagnostics Key Players Head office and Products Offered
Table 16. Companion Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Cancer Diagnostics Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Companion Cancer Diagnostics Market Size Market Share by Regions 2015-2020
Table 21. Americas Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 23. Americas Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 25. Americas Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 27. APAC Companion Cancer Diagnostics Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Companion Cancer Diagnostics Market Size Market Share by Regions (2015-2020)
Table 29. APAC Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 31. APAC Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 33. Europe Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 35. Europe Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 37. Europe Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Companion Cancer Diagnostics Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Companion Cancer Diagnostics Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa Companion Cancer Diagnostics Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Companion Cancer Diagnostics
Table 46. Key Application and Potential Industries of Companion Cancer Diagnostics
Table 47. Key Challenges of Companion Cancer Diagnostics
Table 48. Key Trends of Companion Cancer Diagnostics
Table 49. Global Companion Cancer Diagnostics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Regions
Table 51. Global Companion Cancer Diagnostics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global Companion Cancer Diagnostics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Companion Cancer Diagnostics Market Size Market Share Forecast by Application (2021-2025)
Table 55. F. Hoffmann-La Roche Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 56. F. Hoffmann-La Roche Companion Cancer Diagnostics Product Offered
Table 57. F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Latest Developments
Table 60. Agilent Technologies Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 61. Agilent Technologies Companion Cancer Diagnostics Product Offered
Table 62. Agilent Technologies Main Business
Table 63. Agilent Technologies Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 64. Agilent Technologies Latest Developments
Table 65. Abbott Laboratories Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 66. Abbott Laboratories Companion Cancer Diagnostics Product Offered
Table 67. Abbott Laboratories Main Business
Table 68. Abbott Laboratories Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 69. Abbott Laboratories Latest Developments
Table 70. Almac Group Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 71. Almac Group Companion Cancer Diagnostics Product Offered
Table 72. Almac Group Main Business
Table 73. Almac Group Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 74. Almac Group Latest Developments
Table 75. QIAGEN Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 76. QIAGEN Companion Cancer Diagnostics Product Offered
Table 77. QIAGEN Main Business
Table 78. QIAGEN Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 79. QIAGEN Latest Developments
Table 80. Myriad Genetics Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 81. Myriad Genetics Companion Cancer Diagnostics Product Offered
Table 82. Myriad Genetics Main Business
Table 83. Myriad Genetics Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 84. Myriad Genetics Latest Developments
Table 85. Danaher Corporation Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 86. Danaher Corporation Companion Cancer Diagnostics Product Offered
Table 87. Danaher Corporation Main Business
Table 88. Danaher Corporation Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 89. Danaher Corporation Latest Developments
Table 90. bioM_rieuxSA Details, Company Total Revenue (in $ million), Head Office, Companion Cancer Diagnostics Major Market Areas and Its Competitors
Table 91. bioM_rieuxSA Companion Cancer Diagnostics Product Offered
Table 92. bioM_rieuxSA Main Business
Table 93. bioM_rieuxSA Companion Cancer Diagnostics Revenue and Gross Margin (2018-2020E)
Table 94. bioM_rieuxSA Latest Developments
List of Figures
Figure 1. Companion Cancer Diagnostics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Companion Cancer Diagnostics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Companion Cancer Diagnostics Market Size Market Share by Type (2015-2020)
Figure 5. Global Breast Cancer Market Size Growth Rate
Figure 6. Global Lung Cancer Market Size Growth Rate
Figure 7. Global Colorectal Cancer Market Size Growth Rate
Figure 8. Global Melanoma Market Size Growth Rate
Figure 9. Global Gastric Cancer Market Size Growth Rate
Figure 10. Companion Cancer Diagnostics in Pharmaceutical & Biopharmaceutical Companies
Figure 11. Global Companion Cancer Diagnostics Market: Pharmaceutical & Biopharmaceutical Companies (2015-2020) ($ Millions)
Figure 12. Companion Cancer Diagnostics in Reference Laboratories
Figure 13. Global Companion Cancer Diagnostics Market: Reference Laboratories (2015-2020) ($ Millions)
Figure 14. Companion Cancer Diagnostics in CROs
Figure 15. Global Companion Cancer Diagnostics Market: CROs (2015-2020) ($ Millions)
Figure 16. Global CROs YoY Growth ($ Millions)
Figure 17. Companion Cancer Diagnostics in Others
Figure 18. Global Companion Cancer Diagnostics Market: Others (2015-2020) ($ Millions)
Figure 19. Global Others YoY Growth ($ Millions)
Figure 20. Global Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 21. Global Companion Cancer Diagnostics Market Size Market Share by Regions 2015-2020
Figure 22. Americas Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 23. APAC Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 24. Europe Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Companion Cancer Diagnostics Market Size 2015-2020 ($ Millions)
Figure 26. Americas Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 27. Americas Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 28. Americas Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 29. United States Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Companion Cancer Diagnostics Market Size Market Share by Regions in 2019
Figure 33. APAC Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 34. APAC Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 35. China Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 42. Europe Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 43. Europe Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 44. Germany Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Companion Cancer Diagnostics Market Size Market Share by Application in 2019
Figure 53. Egypt Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Companion Cancer Diagnostics Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Companion Cancer Diagnostics arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 60. APAC Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 61. Europe Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 63. United States Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 64. Canada Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 67. China Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 68. Japan Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 69. Korea Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 71. India Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 72. Australia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 73. Germany Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 74. France Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 75. UK Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 76. Italy Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 77. Russia Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 78. Spain Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 81. Israel Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Companion Cancer Diagnostics Market Size 2021-2025 ($ Millions)
